The Oncology Drugs Markets share is undergoing a dynamic transformation, with adult patients expected to represent a substantial portion of the market. By 2024, this demographic is projected to hold approximately 72% of the market share, reflecting an urgent need for effective cancer therapies tailored for older populations. A significant contributor to the Oncology Drugs Markets share is the...